Measles vaccination: DF extends campaign for people aged 20 to 49 for the second time | Federal District

0
5


The measles vaccination campaign, for people aged 20 to 49, was extended for the second time in the Federal District. The deadline, which would be this Friday (30), has been extended to November 27.

  • Measles: understand what is ‘blocking vaccine’ and ‘booster vaccine’
  • Polio vaccination was also extended until November 27, in the Federal District

According to the Department of Health, immunization coverage is low. According to the folder, from March 23 to October 26, 104,942 people from the Federal District were vaccinated with the triple virus. The group represents 7.7% of the target audience.

Low adherence occurred in all regions of the country, according to the Ministry of Health. national immunization rate in this age group was 13%.

After the end of the national campaign in late October, vaccines will continue to be accessible in Basic Health Units (UBSs). There is a contraindication only for pregnant women and the immunocompromised.

According to the Health Department, vaccination for people aged 20 to 49 is recommended “regardless of how many doses have been recorded in the vaccination booklet”. This is an extra dose to ensure protection against the disease.

“All individuals from 12 months to 29 years of age need to have two doses of the triple viral vaccine, which protects against measles, mumps and rubella. Those from 30 to 59 years old must have at least one dose”, says the Health Department of DF .

“Ask the doctor” talks about measles

In the federal capital, of the five positive cases of the disease registered in 2020, four people are between 20 and 49 years old, the campaign’s age group.

The scenario in DF is similar to the national one. According to the last Epidemiological Bulletin of the Ministry of Health, released on October 3, there were 8,180 cases of the disease across the country.

VIDEOS: see highlights of G1 in 1 Minute

Read more news about the region in G1 DF.

LEAVE A REPLY

Please enter your comment!
Please enter your name here